LEADER 12230nam 2200553 450 001 9910830481503321 005 20230629221910.0 010 $a1-119-67150-7 010 $a1-119-67152-3 010 $a1-119-67153-1 035 $a(CKB)4100000012026905 035 $a(MiAaPQ)EBC6727680 035 $a(Au-PeEL)EBL6727680 035 $a(OCoLC)1276855262 035 $a(EXLCZ)994100000012026905 100 $a20220618d2022 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aBlackwell's five-minute veterinary consult clinical companion $eequine toxicology. /$fedited by Lynn Rolland Hovda, Dionne Benson, Robert H. Poppenga 210 1$aHoboken, New Jersey :$cWiley Blackwell,$d[2022] 210 4$d©2022 215 $a1 online resource (545 pages) 225 1 $aBlackwell's five-minute veterinary consult 311 $a1-119-67149-3 320 $aIncludes bibliographical references and index. 327 $aCover -- Title Page -- Copyright Page -- Contents -- Contributor List -- About the Companion Website -- SECTION I Clinical Toxicology -- Chapter 1 Forensic Investigation of Equine Intoxications -- DEFINITION/OVERVIEW -- SIGNALMENT/HISTORY -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Other Laboratory Tests -- Pathological Findings -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- COMMENTS -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- See Also -- Abbreviations -- Suggested Reading -- Chapter 2 Necropsy Analysis -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- SIGNALMENT/HISTORY -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- THERAPEUTICS -- COMMENTS -- See Also -- Abbreviations -- Suggested Reading -- Chapter 3 Laboratory Testing Considerations -- Background Information -- Communication is Key -- Common Terms and Definitions -- Seeking a Laboratory -- Samples -- Potential Analytical Targets -- Abbreviations -- Suggested Reading -- Chapter 4 Treating an Intoxicated Animal: Antidotes and Therapeutic Medications -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- CBC/Serum Chemistry/Urinalysis -- Other Diagnostic Tests -- Imaging -- THERAPEUTICS -- Goals -- Appropriate Health Care -- Antidotes -- Drug(s) of Choice -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Abbreviations -- Suggested Reading -- Chapter 5 Compounded Medication -- What is Compounding? -- Toxicity and Compounding (see Figs 5.1-5.3) -- Why Extra Caution is Needed for Compounded Products -- Abbreviations -- Internet Resources -- Suggested Reading. 327 $aSECTION II Specific Toxins and Toxicants -- Drugs: Illicit and Recreational -- Chapter 6 Cobalt -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Other Diagnostic Tests -- Pathological Findings -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidote -- Drugs of Choice -- Precautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Abbreviations -- Internet Resources -- Suggested Reading -- Chapter 7 Cocaine -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Serum Samples/Urine Samples -- Other Diagnostic Tests -- Pathological Findings -- THERAPEUTICS -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Expected Course and Prognosis -- Abbreviations -- Suggested Reading -- Chapter 8 Dermorphin -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Pathological Findings -- Therapeutics -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice. 327 $aPrecautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Suggested Reading -- Chapter 9 Growth Hormone and Secretagogues -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- THERAPEUTICS -- Detoxification -- Antidotes -- Appropriate Health Care -- Precautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Abbreviations -- Suggested Reading -- Chapter 10 Marijuana -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- Surgical Considerations -- COMMENTS -- Client Education -- Prevention/Avoidance -- Expected Course and Prognosis -- See Also -- Abbreviations -- Suggested Reading -- Chapter 11 Methamphetamine/Amphetamine -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- COMMENTS -- Client Education -- Behavioral monitoring. -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Abbreviations. 327 $aSuggested Reading -- Chapter 12 Opioids -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry -- Other Diagnostic Tests -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- COMMENTS -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Abbreviations -- Suggested Reading -- Chapter 13 Selective Androgen (SARMS) and Estrogen Receptor (SERMS) Modulators -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Other Diagnostic Tests -- THERAPEUTICS -- Detoxification -- Antidotes -- Appropriate Health Care -- Precautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Suggested Reading -- Chapter 14 Synthetic Cannabinoids -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Toxicokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- CBC/Serum Chemistry/Urinalysis -- Other Diagnostic Tests -- Pathological Findings -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- Abbreviations. 327 $aSuggested Reading -- Drugs: Prescription -- Chapter 15 Antipsychotic Agents - Reserpine and Fluphenazine -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Pharmacokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- Pathological Findings -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- Alternative Drugs -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis -- See Also -- Abbreviations -- Suggested Reading -- Chapter 16 Benzodiazepines -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Pharmacokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- Alternative Drugs -- COMMENTS -- Client Education -- Continued Monitoring -- Expected Course and Prognosis -- Abbreviations -- Suggested Reading -- Chapter 18 Bisphosphonates -- DEFINITION/OVERVIEW -- ETIOLOGY/PATHOPHYSIOLOGY -- Mechanism of Action -- Pharmacokinetics -- Toxicity -- Systems Affected -- SIGNALMENT/HISTORY -- Risk Factors -- Historical Findings -- Location and Circumstances of Poisoning -- CLINICAL FEATURES -- DIFFERENTIAL DIAGNOSIS -- DIAGNOSTICS -- Pathological Findings -- THERAPEUTICS -- Detoxification -- Appropriate Health Care -- Antidotes -- Drugs of Choice -- Precautions/Interactions -- Alternative Drugs -- COMMENTS -- Client Education -- Prevention/Avoidance -- Possible Complications -- Expected Course and Prognosis. 327 $aAbbreviations. 330 $a"Determining underlying causes for sudden or unexplained equine deaths has significant medicolegal importance. Potentially all horses are at risk, but horses are less commonly intoxicated than other species due to more selective dietary habits, more controlled environments, and more observant owners. Clues that might point towards an intoxication include sudden death of one or more otherwise healthy horses, recent feed or environmental changes, easy access to chemical storage areas or trash piles, access to areas with potentially toxic plants, or threats of poisoning. Malicious poisoning does occur due to disputes or in situations in which animals are insured or involved in some form of competition. Determining the cause and manner of death is critical to substantiating claims and the ultimate liability of insurers. A systematic and thorough postmortem examination is essential to confirm death caused by toxicant exposure. Documentation (e.g., use of chain-of-custody procedures) of proper sample collection, storage, and laboratory submission is crucial, especially with accidental feed contamination or malicious poisoning suspicions"--$cProvided by publisher. 410 0$aFive minute veterinary consult. 606 $aVeterinary toxicology 615 0$aVeterinary toxicology. 676 $a636.08959 702 $aHovda$b Lynn R.$f1951- 702 $aBenson$b Dionne 702 $aPoppenga$b Robert H. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910830481503321 996 $aBlackwell's five-minute veterinary consult clinical companion$91567046 997 $aUNINA LEADER 01525nam0 22003251i 450 001 UON00156243 005 20231205102943.333 010 $a75-619-0663-3 100 $a20020225d1999 |0itac50 ba 101 $achi 102 $aCN 105 $a|||| 1|||| 200 1 $aBaokan yuedu jiaocheng$esan nianji jiaocai$f[a cura di] Liu Qiangong, Peng Ruiqing 210 $aBeijing$c Beijin Yuyan Wenhua Daxue chubanshe$d1999 215 $a2 v.$d23 cm 316 $aDono Ambasciata cinese Altro inv. 103445$5IT-UONSI CINIIE/086 (1) N 316 $aDono Ambasciata cinese$5IT-UONSI CINIIE/086 (2) N 410 1$1001UON00156239$12001 $aDuiwai Hanyu benke xilie jiaocai 606 $aLingua cinese$xManuali di insegnamento$3UONC010979$2FI 620 $aCN$dBeijing$3UONL000457 686 $aCIN II E$cCINA - LINGUISTICA - MANUALE DIDATTICO$2A 702 0$aLIU Qiangong$3UONV022190 702 0$aPENG Ruiqing$3UONV092930 712 $aBeijing Yuyan Wenhua Daxue Chubanshe$3UONV251613$4650 801 $aIT$bSOL$c20250516$gRICA 912 $aUON00156243 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI CIN II E 086 (1) N $eSI SA 103444 7 086 (1) N Dono Ambasciata cinese Altro inv. 103445 950 $aSIBA - SISTEMA BIBLIOTECARIO DI ATENEO$dSI CIN II E 086 (2) N $eSI SA 103445 7 086 (2) N Dono Ambasciata cinese 996 $aBaokan yuedu jiaocheng$91286038 997 $aUNIOR